OKYO Pharma logo

OKYO - OKYO Pharma News Story

11.25p -0.3  -2.2%

Last Trade - 4:28pm

Sector
Healthcare
Size
Small Cap
Market Cap £73.2m
Enterprise Value £73.0m
Revenue £n/a
Position in Universe 1053rd / 1803

OKYO Pharma Limited - Upload of Articles of Association to NSM

Fri 25th September, 2020 12:00pm
RNS Number : 1403A
OKYO Pharma Limited
25 September 2020
 

FOR IMMEDIATE RELEASE

 

25 September 2020

OKYO Pharma Limited

(the "Company")

 

Upload of Articles of Association to National Storage Mechanism

 

In accordance with paragraph 9.2.6E of the Listing Rules (disclosure of rights attached to equity shares), the Company has today uploaded to the National Storage Mechanism (NSM) a copy of its Articles of Association, which set out the principal rights and restrictions attached to its ordinary shares.

The NSM can be accessed at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

Enquiries:

OKYO Pharma Limited

Willy Simon

+44 (0)20 7382 8300

Optiva Securities Limited

 

Robert Emmet

+44 (0)20 3981 4173

For further information, please visit the Company's website at www.okyopharma.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAPNSAASEEEA
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.